Handbook of Lymphoma
Editat de Anas Younesen Limba Engleză Paperback – 27 sep 2016
Preț: 121.60 lei
Preț vechi: 128.00 lei
-5% Nou
Puncte Express: 182
Preț estimativ în valută:
23.27€ • 24.11$ • 19.42£
23.27€ • 24.11$ • 19.42£
Carte disponibilă
Livrare economică 28 februarie-14 martie
Livrare express 13-19 februarie pentru 20.64 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783319084664
ISBN-10: 3319084666
Pagini: 96
Ilustrații: XV, 112 p. 7 illus. in color.
Dimensiuni: 127 x 203 x 7 mm
Greutate: 0.14 kg
Ediția:1st ed. 2016
Editura: Springer International Publishing
Colecția Adis
Locul publicării:Cham, Switzerland
ISBN-10: 3319084666
Pagini: 96
Ilustrații: XV, 112 p. 7 illus. in color.
Dimensiuni: 127 x 203 x 7 mm
Greutate: 0.14 kg
Ediția:1st ed. 2016
Editura: Springer International Publishing
Colecția Adis
Locul publicării:Cham, Switzerland
Public țintă
Professional/practitionerCuprins
Introduction.- Risk factors, etiology, and pathogenesis.- World Health Organization classification.- Staging.- Treatment overview.- Treatment of B-cell lymphomas.- Treatment of T-cell lymphomas.- Treatment of Hodgkin lymphoma.- Management of human immunodeficiency virus-associated lymphomas
Notă biografică
Anas Younes, MD, is the Chief of the Lymphoma Service at Memorial Sloan Kettering Cancer Center and Professor of
Medicine at Weill-Cornell Medical College, New York, NY, USA. He has extensive experience in clinical and translational research in lymphoma. He was the Principal Investigator of the MD Anderson Cancer Center Lymphoma
SPORE grant, and is currently the Principal Investigator of the Memorial Sloan Kettering Cancer Center Lymphoma SPORE grant. He has lead more than 60 clinical trials in lymphoma. He has lead, in collaboration with colleagues from around the world, the pivotal trials that resulted in the US FDA approval of brentuximab vedotin and nivolumab for the treatment of patients with relapsed Hodgkin lymphoma. He has published more than 250 papers on lymphoma.
Medicine at Weill-Cornell Medical College, New York, NY, USA. He has extensive experience in clinical and translational research in lymphoma. He was the Principal Investigator of the MD Anderson Cancer Center Lymphoma
SPORE grant, and is currently the Principal Investigator of the Memorial Sloan Kettering Cancer Center Lymphoma SPORE grant. He has lead more than 60 clinical trials in lymphoma. He has lead, in collaboration with colleagues from around the world, the pivotal trials that resulted in the US FDA approval of brentuximab vedotin and nivolumab for the treatment of patients with relapsed Hodgkin lymphoma. He has published more than 250 papers on lymphoma.
Caracteristici
A clinically focused handbook providing healthcare professionals with a comprehensive guide to the current and emerging treatment options in Hodgkin and non-Hodgkin lymphoma
Includes timely research written by leading experts in the field
Easily accessible text and figures offer practical approaches for managing lymphoma
Explores issues of vital interest to the research community
Includes supplementary material: sn.pub/extras
Includes timely research written by leading experts in the field
Easily accessible text and figures offer practical approaches for managing lymphoma
Explores issues of vital interest to the research community
Includes supplementary material: sn.pub/extras